CREYX | VGSIX | CREYX / VGSIX | |
Total Expense Ratio | 0.86 | 0.27 | 319% |
Annual Report Gross Expense Ratio | 0.86 | 0.27 | 319% |
Fund Existence | 8 years | 29 years | - |
Gain YTD | -2.100 | 2.993 | -70% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 3000 | 33,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 156M | 63.6B | 0% |
Annual Yield % from dividends | 2.60 | 3.75 | 69% |
Returns for 1 year | 2.47 | 12.01 | 21% |
Returns for 3 years | -15.98 | 9.66 | -165% |
Returns for 5 years | -9.04 | 35.11 | -26% |
Returns for 10 years | N/A | 63.80 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MBGFX | 20.89 | 0.22 | +1.06% |
MassMutual Blue Chip Growth R4 | |||
WCMVX | 18.28 | 0.09 | +0.49% |
WCM Focused International Equity Ins | |||
IJMIX | 16.64 | 0.07 | +0.42% |
VY® JPMorgan Mid Cap Value I | |||
TSHIX | 15.25 | 0.06 | +0.39% |
Transamerica Multi-Asset Income I | |||
PRHSX | 77.35 | 0.27 | +0.35% |
T. Rowe Price Health Sciences |